Active Pharmaceutical Ingredients - Global Market Outlook (2017-2026)

Published by StratisticsMRC on 1st September 2018 | Ref: 1067654 | This Report Is In Stock

$4150 | Single User
$6350 | Site License
$7500 | Enterprise License
$4150 | Single User
$6350 | Site License
$7500 | Enterprise License

Introduction

According to Stratistics MRC, the Global Active Pharmaceutical Ingredients Market is accounted for 1.89 billion in 2017 and is expected to reach 8.48 billion by 2026 growing at a CAGR of 8.2% from 2017 to 2026. Increase in incidence of chronic diseases, rising prevalence of cancer, technological advancements in API manufacturing, growing importance of generics, rapidly increasing geriatric population, increase in abbreviated new drug applications (ANDA) and increasing uptake of biopharmaceuticals are some factors fueling the market growth. However, factors such as stringent regulatory requirements and unfavorable drug price control policies across various countries are restricting the market growth.


Active pharmaceutical ingredients are any substance or combination of substances used in a finished pharmaceutical product with pharmacological activity. Active Pharmaceutical Ingredients are chemically and biologically active components of drugs with direct effect in cure, mitigation, treatment and prevention of diseases. An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.


Amongst Customer Base, Generic segment accounted for significant market share during the forecast period. Generic drugs benefit from the patent expiration of innovative drug as it makes them readily available in the market. The demand to produce quality medicines at lower and affordable costs creates a scenario, where the needs for generic drugs increase. By geography, Asia Pacific dominated the market due to the rising healthcare spending which has led to quality healthcare becoming accessible along with a higher demand for pharmaceutical products across APAC. The pharmaceuticals consumed here are mostly produced in onshore manufacturing units. Furthermore, contract manufacturing organizations are key outsourcing allies for pharmaceutical companies that supply their wares across the region.

Some of the key players in Active Pharmaceutical Ingredients market include Teva Active Pharmaceutical Industries Limited, Ranbaxy Laboratories, Pfizer, Inc, Novartis, Mylan N.V, Lupin, Dr. Reddy's Lab, Boehringer Ingelheim GmbH, Aurobindo pharma, Albemarle Corporation, Ceva Animal Health, Inc., Virbac, Sun Pharmaceutical Industries Ltd., Merck Animal Health (U.S.), Elanco Animal Health (U.S.), Zoetis (U.S.), Merial Inc. (Sanofi) (France), Bioniche Animal Health (Canada), Bayer Healthcare (Germany), ELI Lilly and Company, Glaxosmithkline PLC, Abbvie Inc., Sanofi and Bristol-Myers Squibb.

Drug Types Covered:

• Generic Prescription

• Innovative Drugs

• Over-the-counter (OTC) Drugs

• Prescription Drugs

• Potency

API Formulations Covered:

• Innovative API

• Generic API

Type of Manufacturers Covered:

• Contract Manufacturers

• Captive Manufacturers

• Merchant API Manufacturers

Type of Synthesises Covered:

• Biotech Active Pharmaceutical Ingredients

• Synthetic Active Pharmaceutical Ingredients

API Types Covered:

• Biological API

• Chemical API

Molecules Covered:

• Large Molecule

• Small Molecule

Applications Covered:

• Anti-diabetic Drugs

• Cardiovascular Disease

• Central Nervous System and Neurological Disorders

• Diabetes

• Endocrinology

• Gastrointestinal Disorders

• Musculoskeletal drugs

• Non-steroidal Anti-inflammatory Drugs

• Oncology

• Orthopedic Disorders

• Respiratory

• Urology

• Other Applications

Regions Covered:

• North America

o US

o Canada

o Mexico

• Europe

o Germany

o UK

o Italy

o France

o Spain

o Rest of Europe

• Asia Pacific

o Japan

o China

o India

o Australia

o New Zealand

o South Korea

o Rest of Asia Pacific

• South America

o Argentina

o Brazil

o Chile

o Rest of South America

• Middle East & Africa

o Saudi Arabia

o UAE

o Qatar

o South Africa

o Rest of Middle East & Africa

What our report offers:

- Market share assessments for the regional and country level segments

- Market share analysis of the top industry players

- Strategic recommendations for the new entrants

- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets

- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)

- Strategic recommendations in key business segments based on the market estimations

- Competitive landscaping mapping the key common trends

- Company profiling with detailed strategies, financials, and recent developments

- Supply chain trends mapping the latest technological advancements

Table of Contents

1 Executive Summary

2 Preface

2.1 Abstract

2.2 Stake Holders

2.3 Research Scope

2.4 Research Methodology

2.5 Research Sources

3 Market Trend Analysis

3.1 Introduction

3.2 Drivers

3.3 Restraints

3.4 Opportunities

3.5 Threats

3.6 Application Analysis

3.7 Emerging Markets

3.8 Futuristic Market Scenario

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers

4.2 Bargaining power of buyers

4.3 Threat of substitutes

4.4 Threat of new entrants

4.5 Competitive rivalry

5 Global Active Pharmaceutical Ingredients Market, By Drug Type

5.1 Introduction

5.2 Generic Prescription

5.3 Innovative Drugs

5.4 Over-the-counter (OTC) Drugs

5.5 Prescription Drugs

5.6 Potency

6 Global Active Pharmaceutical Ingredients Market, By API Formulation

6.1 Introduction

6.2 Innovative API

6.3 Generic API

7 Global Active Pharmaceutical Ingredients Market, By Type of Manufacturer

7.1 Introduction

7.2 Contract Manufacturers

7.3 Captive Manufacturers

7.4 Merchant API Manufacturers

8 Global Active Pharmaceutical Ingredients Market, By Type of Synthesis

8.1 Introduction

8.2 Biotech Active Pharmaceutical Ingredients

8.3 Synthetic Active Pharmaceutical Ingredients

9 Global Active Pharmaceutical Ingredients Market, By API Type

9.1 Introduction

9.2 Biological API

9.3 Chemical API

10 Global Active Pharmaceutical Ingredients Market, By Molecule

10.1 Introduction

10.2 Large Molecule

10.3 Small Molecule

11 Global Active Pharmaceutical Ingredients Market, By Application

11.1 Introduction

11.2 Anti-diabetic Drugs

11.3 Cardiovascular Disease

11.4 Central Nervous System and Neurological Disorders

11.5 Diabetes

11.6 Endocrinology

11.7 Gastrointestinal Disorders

11.8 Musculoskeletal drugs

11.9 Non-steroidal Anti-inflammatory Drugs

11.10 Oncology

11.11 Orthopedic Disorders

11.12 Respiratory

11.13 Urology

11.14 Other Applications

12 Global Active Pharmaceutical Ingredients Market, By Geography

12.1 Introduction

12.2 North America

12.3 Europe

12.4 Asia Pacific

12.5 South America

12.6 Middle East & Africa

13 Key Developments

13.1 Agreements, Partnerships, Collaborations and Joint Ventures

13.2 Acquisitions & Mergers

13.3 New Product Launch

13.4 Expansions

13.5 Other Key Strategies

14 Company Profiling

14.1 Teva Active Pharmaceutical Industries Limited

14.2 Ranbaxy Laboratories

14.3 Pfizer, Inc

14.4 Novartis

14.5 Mylan N.V

14.6 Lupin

14.7 Dr. Reddy's Lab

14.8 Boehringer Ingelheim GmbH

14.9 Aurobindo pharma

14.10 Albemarle Corporation

14.11 Ceva Animal Health, Inc.

14.12 Virbac

14.13 Sun Pharmaceutical Industries Ltd.

14.14 Merck Animal Health (U.S.)

14.15 Elanco Animal Health (U.S.)

14.16 Zoetis (U.S.)

14.17 Merial Inc. (Sanofi) (France)

14.18 Bioniche Animal Health (Canada)

14.19 Bayer Healthcare (Germany)

14.20 ELI Lilly and Company

14.21 Glaxosmithkline PLC

14.22 Abbvie Inc.

14.23 Sanofi

14.24 Bristol-Myers Squibb

List of Tables

Table 1 Global Active Pharmaceutical Ingredients Market Outlook, By Region (2016-2026) (US $MN)

Table 2 Global Active Pharmaceutical Ingredients Market Outlook, By Drug Type (2016-2026) (US $MN)

Table 3 Global Active Pharmaceutical Ingredients Market Outlook, By Generic Prescription (2016-2026) (US $MN)

Table 4 Global Active Pharmaceutical Ingredients Market Outlook, By Innovative Drugs (2016-2026) (US $MN)

Table 5 Global Active Pharmaceutical Ingredients Market Outlook, By Over-the-counter (OTC) Drugs (2016-2026) (US $MN)

Table 6 Global Active Pharmaceutical Ingredients Market Outlook, By Prescription Drugs (2016-2026) (US $MN)

Table 7 Global Active Pharmaceutical Ingredients Market Outlook, By Potency (2016-2026) (US $MN)

Table 8 Global Active Pharmaceutical Ingredients Market Outlook, By Low to Moderate Potency (2016-2026) (US $MN)

Table 9 Global Active Pharmaceutical Ingredients Market Outlook, By Potent to Highly Potent (2016-2026) (US $MN)

Table 10 Global Active Pharmaceutical Ingredients Market Outlook, By API Formulation (2016-2026) (US $MN)

Table 11 Global Active Pharmaceutical Ingredients Market Outlook, By Innovative API (2016-2026) (US $MN)

Table 12 Global Active Pharmaceutical Ingredients Market Outlook, By Generic API (2016-2026) (US $MN)

Table 13 Global Active Pharmaceutical Ingredients Market Outlook, By Type of Manufacturer (2016-2026) (US $MN)

Table 14 Global Active Pharmaceutical Ingredients Market Outlook, By Contract Manufacturers (2016-2026) (US $MN)

Table 15 Global Active Pharmaceutical Ingredients Market Outlook, By Captive Manufacturers (2016-2026) (US $MN)

Table 16 Global Active Pharmaceutical Ingredients Market Outlook, By Merchant API Manufacturers (2016-2026) (US $MN)

Table 17 Global Active Pharmaceutical Ingredients Market Outlook, By Generic Merchant API Manufacturers (2016-2026) (US $MN)

Table 18 Global Active Pharmaceutical Ingredients Market Outlook, By Innovative Merchant API Manufacturers (2016-2026) (US $MN)

Table 19 Global Active Pharmaceutical Ingredients Market Outlook, By Type of Synthesis (2016-2026) (US $MN)

Table 20 Global Active Pharmaceutical Ingredients Market Outlook, By Biotech Active Pharmaceutical Ingredients (2016-2026) (US $MN)

Table 21 Global Active Pharmaceutical Ingredients Market Outlook, By Type (2016-2026) (US $MN)

Table 22 Global Active Pharmaceutical Ingredients Market Outlook, By Expression System (2016-2026) (US $MN)

Table 23 Global Active Pharmaceutical Ingredients Market Outlook, By Product (2016-2026) (US $MN)

Table 24 Global Active Pharmaceutical Ingredients Market Outlook, By Synthetic Active Pharmaceutical Ingredients (2016-2026) (US $MN)

Table 25 Global Active Pharmaceutical Ingredients Market Outlook, By Generic Synthetic APIs (2016-2026) (US $MN)

Table 26 Global Active Pharmaceutical Ingredients Market Outlook, By Innovative Synthetic APIs (2016-2026) (US $MN)

Table 27 Global Active Pharmaceutical Ingredients Market Outlook, By API Type (2016-2026) (US $MN)

Table 28 Global Active Pharmaceutical Ingredients Market Outlook, By Biological API (2016-2026) (US $MN)

Table 29 Global Active Pharmaceutical Ingredients Market Outlook, By Chemical API (2016-2026) (US $MN)

Table 30 Global Active Pharmaceutical Ingredients Market Outlook, By Molecule (2016-2026) (US $MN)

Table 31 Global Active Pharmaceutical Ingredients Market Outlook, By Large Molecule (2016-2026) (US $MN)

Table 32 Global Active Pharmaceutical Ingredients Market Outlook, By Small Molecule (2016-2026) (US $MN)

Table 33 Global Active Pharmaceutical Ingredients Market Outlook, By Application (2016-2026) (US $MN)

Table 34 Global Active Pharmaceutical Ingredients Market Outlook, By Anti-diabetic Drugs (2016-2026) (US $MN)

Table 35 Global Active Pharmaceutical Ingredients Market Outlook, By Cardiovascular Disease (2016-2026) (US $MN)

Table 36 Global Active Pharmaceutical Ingredients Market Outlook, By Central Nervous System and Neurological Disorders (2016-2026) (US $MN)

Table 37 Global Active Pharmaceutical Ingredients Market Outlook, By Diabetes (2016-2026) (US $MN)

Table 38 Global Active Pharmaceutical Ingredients Market Outlook, By Endocrinology (2016-2026) (US $MN)

Table 39 Global Active Pharmaceutical Ingredients Market Outlook, By Gastrointestinal Disorders (2016-2026) (US $MN)

Table 40 Global Active Pharmaceutical Ingredients Market Outlook, By Musculoskeletal drugs (2016-2026) (US $MN)

Table 41 Global Active Pharmaceutical Ingredients Market Outlook, By Non-steroidal Anti-inflammatory Drugs (2016-2026) (US $MN)

Table 42 Global Active Pharmaceutical Ingredients Market Outlook, By Oncology (2016-2026) (US $MN)

Table 43 Global Active Pharmaceutical Ingredients Market Outlook, By Orthopedic Disorders (2016-2026) (US $MN)

Table 44 Global Active Pharmaceutical Ingredients Market Outlook, By Respiratory (2016-2026) (US $MN)

Table 45 Global Active Pharmaceutical Ingredients Market Outlook, By Urology (2016-2026) (US $MN)

Table 46 Global Active Pharmaceutical Ingredients Market Outlook, By Other Applications (2016-2026) (US $MN)

NOTE: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa are represented in the same manner above.

Additional Details

Publisher

StratisticsMRC

Publisher Information

Reference

1067654 |

Number of Pages

151

Report Format

PDF

This report is published by StratisticsMRC

Download Free Report Summary PDF

Active Pharmaceutical Ingredients - Global Market Outlook (2017-2026) [Updated: 01-09-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.